Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Current FDA-approved GLP-1 drugs available on the market include: Byetta (exenatide) Foundayo (orforglipron) Trulicity (dulaglutide), Victoza, Saxenda, Xultophy (liraglutide) Ozempic, Rybelsus, Wegovy (semaglutide) Mounjaro, Zepbound (tirzepatide) While all GLP-1 drugs can cause weight loss as a side effect, only Wegovy, Saxenda, Foundayo, and Zepbound are FDA approved for weight loss
Current Opinion in Endocrinology, Diabetes, and Obesity, 19 (2), 81-87
[PMID: 40094647] PubMed record related to this compound for laboratory literature review
Renassia C, Peyssonnaux C
US$ 21.84
US$ 20.35
US$ 27.74
US$ 21.06
